Fat Reduction Clinical Trial
— CellulizeOfficial title:
Effects of Green Light Therapy on Body Contouring and Cellulite
NCT number | NCT03647748 |
Other study ID # | CP16-02 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | January 2017 |
Est. completion date | August 2018 |
Verified date | August 2018 |
Source | Ward Photonics LLC |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
A double-blind, placebo-controlled randomized evaluation of the effect of Cellulize, a green light low level laser system for aesthetic use for the non-invasive reduction in fat layer for body contouring and reduction of cellulite.
Status | Completed |
Enrollment | 52 |
Est. completion date | August 2018 |
Est. primary completion date | August 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Study participant between the ages of 18 and older. - Female only - Subject is willing and able to abstain from partaking in any treatment other than the study procedures (existing or new) to promote body contouring/circumference reduction/weight loss during the course of study participation. - Subject is willing and able to maintain his or her regular (typical pre-study) diet and exercise regimen without effecting significant change in either direction during study participation. Exclusion Criteria: - No photo-therapy (red or green) within 3 weeks of treatment. - Known cardiovascular disease such as cardiac arrhythmias, congestive heart failure. - Cardiac surgeries such as cardiac bypass, heart transplant surgery, pacemakers. - Prior surgical intervention for body sculpting/weight loss, such as liposuction, abdominoplasty, stomach stapling, lap band surgery, etc. - Medical, physical, or other contraindications for body sculpting/weight loss. - Current use of medication(s) known to affect weight levels/cause bloating or swelling and for which abstinence during the course of study participation is not safe or medically prudent. - Any medical condition known to affect weight levels and/or to cause bloating or swelling. - Active infection, open wound (e.g. sores, cuts, ulcers, burns, etc.) or other external trauma to the areas to be treated with the laser/lymphatic drainage system devices. - Photosensitive condition or medication. - Active cancer within the past year. - Pregnant, possibly pregnant or planning pregnancy prior to the end of study participation. - Diminished ability to void waste (liver or kidneys). - Developmental disability or cognitive impairment that in the opinion of the investigator would preclude adequate comprehension of the informed consent form and/or ability to record the necessary study measurements. |
Country | Name | City | State |
---|---|---|---|
United States | Michigan Center for Cosmetic Surgery, Ann Arbor, Michigan | Ann Arbor | Michigan |
United States | Wunderlich Chiropractic Clinic | Cape Coral | Florida |
United States | Mobile Laser Slimming | Cocoa Beach | Florida |
United States | Lake Mary Health and Wellness | Lake Mary | Florida |
Lead Sponsor | Collaborator |
---|---|
Ward Photonics LLC |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Average Change in Inches of Total Circumference Measurements | Average Change in Inches of Total Circumference Measurements for effect of Cellulize, a LED 532nm green light low level laser system for aesthetic use for the non-invasive reduction in fat layer for body contouring from baseline measurements, and after treatment. | 2 weeks | |
Secondary | Durability of Effect | Durability of Effect: a term used to indicate whether the results of the primary outcome endure at the 2 week follow up time point. If the average change in inches of total circumference continues decreasing or stays the same, then the durability of effect is assumed to endure for at least two weeks. If the measurements at the 2-week time point show that the changes in inches return to previous measures at the start of treatment, then the effect is considered temporary. | 2 weeks | |
Secondary | Change in appearance of cellulite | Change in appearance of cellulite is a measure of the Nurnberger-Muller Scale (NMS) from baseline to 2 weeks post-assessment for both of the right and left thighs. | 2 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05256771 -
Electrical Muscle Stimulation With 1064 nm Diode Laser and RF/PEMF for Non-invasive Body Contouring and Fat Reduction.
|
N/A | |
Completed |
NCT01101997 -
Non-Invasive Reduction of Abdominal Fat
|
N/A | |
Completed |
NCT03241563 -
Subcutaneous Sodium Deoxycholate Injections With or Without Triamcinolone for Reduction of Submental Fat
|
Phase 4 |